Combination therapy for branch retinal vein occlusion

References

• Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog. Retin. Eye Res.24, 493–519 (2005).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans. Am. Ophthalmol. Soc.98, 133–141; discussion I41–I43 (2000).
   PubMedGoogle Scholar
• Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch. Ophthalmol.114, 1243–1247 (1996).
   PubMed Web of Science ®Google Scholar
• Feist RM, Ticho BH, Shapiro MJ, Farber M. Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. Am. J. Ophthalmol.113, 664–668 (1992).
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am. J. Ophthalmol.117, 429–441 (1994).
   PubMed Web of Science ®Google Scholar
• Rogers SL, McIntosh RL, Lim L et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology117, 1094–1101 (2010).
   PubMed Web of Science ®Google Scholar
• Cahill MT, Fekrat S. Arteriovenous sheathotomy for branch retinal vein occlusion. Ophthalmol. Clin. North Am.15, 417–423 (2002).
   PubMedGoogle Scholar
• Ikuno Y, Ikeda T, Sato Y, Tano Y. Tractional retinal detachment after branch retinal vein occlusion. Influence of disc neovascularization on the outcome of vitreous surgery. Ophthalmology105, 417–423 (1998).
   PubMed Web of Science ®Google Scholar
• Scott IU, Ip MS, Van Veldhuisen PC et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch. Ophthalmol.127, 1115–1128 (2009).
   PubMed Web of Science ®Google Scholar
• Pai SA, Shetty R, Vijayan PB et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am. J. Ophthalmol.143, 601–606 (2007).
   PubMed Web of Science ®Google Scholar
• Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc. Ophthalmol.97, 465–469 (1999).
   PubMed Web of Science ®Google Scholar
• Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina22, 740–746 (2002).
   PubMed Web of Science ®Google Scholar
• Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina19, 1–5 (1999).
   PubMed Web of Science ®Google Scholar
• Hwang JC, Gelman SK, Fine HF, Chang S, Priore LVD. Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch vein occlusion. Br. J. Ophthalmol.94, 1483–1489 (2010).
   PubMed Web of Science ®Google Scholar
• Roseman RL, Olk RJ. Krypton red laser photocoagulation for branch retinal vein occlusion. Ophthalmology94, 1120–1125 (1987).
   PubMed Web of Science ®Google Scholar
• Stefansson E. Treatment of branch retinal vein occlusion. Acta Ophthalmol.86, 122–123 (2008).
   PubMed Web of Science ®Google Scholar
• The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am. J. Ophthalmol.98, 271–282 (1984).
   PubMed Web of Science ®Google Scholar
• McAllister IL, Yu DY, Vijayasekaran S, Barry C, Constable I. Induced chorioretinal venous anastomosis in experimental retinal branch vein occlusion. Br. J. Ophthalmol.76, 615–620 (1992).
   PubMed Web of Science ®Google Scholar
• Degenring RF, Kamppeter B, Kreissig I, Jonas JB. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol. Scand.81, 548–550 (2003).
   PubMedGoogle Scholar
• Kawaji T, Hirata A, Awai N et al. Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy. Am. J. Ophthalmol.140, 540–542 (2005).
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Okada AA, Morimura Y et al. Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion. Retina24, 964–967 (2004).
   PubMed Web of Science ®Google Scholar
• Haller JA, Bandello F, Belfort R Jr et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology117(6), 1134–1146 (2010).
   PubMed Web of Science ®Google Scholar
• Stahl A, Agostini H, Hansen LL, Feltgen N. Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch. Clin. Exp. Ophthalmol.245, 1429–1436 (2007).
   PubMed Web of Science ®Google Scholar
• Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Blasco H, Corcostegui B. Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina24, 530–540 (2004).
   PubMed Web of Science ®Google Scholar
• Murakami T, Takagi H, Kita M et al. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion. Am. J. Ophthalmol.142, 318–320 (2006).
   PubMed Web of Science ®Google Scholar
• Lazo-Langner A, Hawel J, Ageno W, Kovacs MJ. Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica95, 1587–1593 (2010).
   PubMed Web of Science ®Google Scholar
• Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest. Ophthalmol. Vis. Sci.31, 284–289 (1990).
   PubMed Web of Science ®Google Scholar
• Kumagai K, Ogino N, Furukawa M et al. Vitreous surgery for macular edema in branch retinal vein occlusion. Nippon Ganka Gakkai Zasshi106, 701–707 (2002).
   PubMedGoogle Scholar
• Saika S, Tanaka T, Miyamoto T, Ohnishi Y. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch. Clin. Exp. Ophthalmol.239, 729–732 (2001).
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Cetinkaya K, Kapicioglu Z, Kaya C. The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol. Scand.75, 441–442 (1997).
   PubMedGoogle Scholar
• Takahashi MK, Hikichi T, Akiba J, Yoshida A, Trempe CL. Role of the vitreous and macular edema in branch retinal vein occlusion. Ophthalmic Surg. Lasers28, 294–299 (1997).
   PubMedGoogle Scholar
• Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina24, 348–355 (2004).
   PubMed Web of Science ®Google Scholar
• Charbonnel J, Glacet-Bernard A, Korobelnik JF et al. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch. Clin. Exp. Ophthalmol.242, 223–228 (2004).
   PubMed Web of Science ®Google Scholar
• Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology108, 2249–2257 (2001).
   PubMed Web of Science ®Google Scholar
• Kaiser PK. Vascular endothelial growth factor Trap-Eye for diabetic macular oedema. Br. J. Ophthalmol.93, 135–136 (2009).
   PubMed Web of Science ®Google Scholar
• Muqit MM, Saidkasimova S, Keating D, Murdoch JR. Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion. Acta Ophthalmol.88, e57–e65 (2010).
   Google Scholar
• Kuhn F, Kiss G, Mester V, Szijarto Z, Kovacs B. Vitrectomy with internal limiting membrane removal for clinically significant macular edema. Graefes Arch. Clin. Exp. Ophthalmol.242, 402–408 (2004).
   PubMed Web of Science ®Google Scholar